Eli Lilly Corp. buy gerihouse
Start price
09.10.12
/
50%
€39.56
Target price
21.02.13
€45.00
Performance (%)
5.46%
End price
21.02.13
€40.97
Summary
This prediction ended on 21.02.13 with a price of €40.97. With a performance of 5.46%, the BUY prediction by gerihouse for Eli Lilly Corp. closed with a slight gain. gerihouse has a follow-up prediction for Eli Lilly Corp. where he still thinks Eli Lilly Corp. is a Buy. gerihouse has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Eli Lilly Corp. | -0.762% | -0.762% | 106.426% | 345.394% |
| iShares Core DAX® | -1.785% | -1.250% | 11.664% | 12.714% |
| iShares Nasdaq 100 | -2.154% | 0.300% | 37.531% | 41.653% |
| iShares Nikkei 225® | -4.028% | -3.746% | 17.142% | 0.393% |
| iShares S&P 500 | -1.969% | 0.307% | 25.617% | 40.084% |
According to gerihouse what are the pros and cons of Eli Lilly Corp. for the foreseeable future?
Pros
Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
Future proof or reliable business model
Small cyclical dependencies
Well known brand
Revenue growth >5% per year expected
Cons
Comments by gerihouse for this prediction
In the thread Eli Lilly Corp. diskutieren
Gute Pharamaktie
Der US-Pharmakonzern Eli Lilly meldet weitere Fortschritte bei der Forschung nach einem Wirkstoff gegen die Krankheit Alzheimer. Eine unabhängige Analyse von vorliegenden Daten zu dem Wirkstoff Solanezumab durch eine Forschergruppe der University of California bestätigt eine Einschätzung der vorliegenden Studienergebnisse von Eli Lilly aus dem August.
Demnach bewirke das Präparat bei Alzheimerpatienten in einem frühen Stadium eine statistische signifikante Verlangsamung ihres Voranschreitens. Seit der Veröffentlichung der ersten Resultate zu dem Mittel im August legte die Aktie um mehr als 17 Prozent zu.
(Vom Mitglied beendet)
Current prediction by gerihouse for Eli Lilly Corp.
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€546.50
16.11.23
16.11.23
€740.00
16.11.24
16.11.24
29.30%
12:07
12:07
Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
Stopped prediction by gerihouse for Eli Lilly Corp.
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€370.05
04.11.22
04.11.22
€610.00
04.11.23
04.11.23
44.17%
05.11.23
05.11.23
Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€213.80
18.01.22
18.01.22
€350.00
18.01.23
18.01.23
47.33%
23.09.22
23.09.22
Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€173.98
25.01.21
25.01.21
€250.00
25.01.22
25.01.22
23.00%
17.01.22
17.01.22
Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€126.32
18.03.20
18.03.20
€150.00
12.10.20
12.10.20
6.54%
12.10.20
12.10.20
Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€98.78
13.10.19
13.10.19
€120.00
26.10.19
26.10.19
0.30%
26.10.19
26.10.19
Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€104.32
06.09.19
06.09.19
€120.00
13.10.19
13.10.19
-5.58%
13.10.19
13.10.19
Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€103.80
24.06.19
24.06.19
€130.79
06.09.19
06.09.19
0.94%
06.09.19
06.09.19
Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€102.30
18.04.19
18.04.19
€120.00
24.05.19
24.05.19
3.46%
24.05.19
24.05.19
Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€106.63
24.01.19
24.01.19
€126.28
04.04.19
04.04.19
6.26%
04.04.19
04.04.19
Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€71.74
10.05.18
10.05.18
€99.22
06.09.18
06.09.18
32.15%
06.09.18
06.09.18
Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€68.59
31.08.17
31.08.17
€80.00
10.11.17
10.11.17
3.37%
10.11.17
10.11.17
Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€71.74
10.11.16
10.11.16
€85.00
18.04.17
18.04.17
8.26%
18.04.17
18.04.17
Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€63.10
24.03.16
24.03.16
€90.00
08.08.16
08.08.16
16.05%
08.08.16
08.08.16
Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€71.93
13.10.15
13.10.15
€90.20
04.01.16
04.01.16
4.66%
04.01.16
04.01.16
Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€65.85
05.05.15
05.05.15
€83.00
22.07.15
22.07.15
19.78%
22.07.15
22.07.15
Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€49.89
11.09.14
11.09.14
€60.00
24.11.14
24.11.14
8.90%
24.11.14
24.11.14
Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€34.30
04.07.12
04.07.12
€40.00
05.09.12
05.09.12
8.03%
05.09.12
05.09.12
Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative